EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Assessment of clinical efficacy and tolerability of terconazole 240-mg vaginal suppositories



Assessment of clinical efficacy and tolerability of terconazole 240-mg vaginal suppositories



Gynakologische Rundschau 25 Suppl 1: 59-66



Studies in 128 women with vaginal candidosis showed that a single-dose treatment with a 240-mg vaginal suppository of terconazole was effective and well tolerated.

(PDF emailed within 1 workday: $29.90)

Accession: 001533027

Download citation: RISBibTeXText

PMID: 4007623



Related references

Demonstration of effectiveness and tolerability of terconazole 80-mg vaginal suppositories (3 days) versus terconazole 240-mg vaginal suppositories (1 day) versus clotrimazole 200-mg vaginal tablets (3 days) in non-pregnant women with vulvovaginal candidosis. Gynakologische Rundschau 25 Suppl 1: 99-104, 1985

Terconazole cream and suppositories: plasma terconazole following vaginal administration. Gynakologische Rundschau 25 Suppl 1: 26-32, 1985

Comparative double-blind evaluation of the efficacy and tolerability of terconazole 240-mg suppository (1 day) and 80-mg suppositories (3 days) versus clotrimazole 200-mg (3 days) in pregnant patients with vulvovaginal candidosis. Gynakologische Rundschau 25 Suppl 1: 74-82, 1985

Treatment of vaginal candidosis with three 80 mg terconazole vaginal suppositories: results of a multicentre study in France. Gynakologische Rundschau 25(Suppl. 1): 52-58, 1985

Advantages of a 6- to 7-day treatment with 40 mg vaginal suppositories of terconazole against vaginal candidosis: conclusion drawn from a Phase II multicentre study in France. Gynakologische Rundschau 25(Suppl. 1): 42-51, 1985

Single-day topical treatment of vaginal candidosis: an open evaluation of terconazole 240-mg vaginal suppositories versus isoconazole tablets 600 mg. Gynakologische Rundschau 25 Suppl 1: 90-98, 1985

Terconazole 0.8% vaginal cream (5 days) versus clotrimazole 1% (6 days): efficacy and tolerability in an open study. Gynakologische Rundschau 25 Suppl 1: 33-41, 1985

Clinical assessment of the efficacy and tolerability of nimorazole in the treatment of vaginal trichomoniasis. Minerva Ginecologica 31(3): 155-162, 1979

A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis. Medical Mycology 53(5): 455-461, 2016

Clinical study of the efficacy and tolerability of nimesulide in suppositories compared to flurbiprofen in gynecology. Minerva Ginecologica 42(10): 413-419, 1990

Vaginal infections of mixed etiology. Clinical importance and study of the efficacy and tolerability of 2 different treatments (25,000 I.U. mepartricin vaginal tablets and 100 mg. clotrimazole vaginal tablets). Minerva Ginecologica 36(12): 843-849, 1984

Efficacy, tolerability and safety of a new medical device, Monurelle Biogel(®) vaginal gel, in the treatment of vaginal dryness: a randomized clinical trial in women of reproductive age. European Journal of Obstetrics, Gynecology, and Reproductive Biology 203(): 82-88, 2016

Evaluation of the efficacy and tolerability of two different dosages of fenticonazole vaginal ovules (600 MG and 1000 MG) in patients with vaginal trichomoniasis: A controlled, double-blind, randomized clinical trial versus placebo. Current Therapeutic Research 55(5): 510-518, 1994